Search Results - "Samuel, Didier"

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation by Samuel, Didier, Coilly, Audrey

“…The results of liver transplantation are excellent, with survival rates of over 90 and 80% at 1 and 5 years, respectively. The success of liver transplantation…”
Get full text

Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma by Job, Sylvie, Rapoud, Delphine, Dos Santos, Alexandre, Gonzalez, Patrick, Desterke, Christophe, Pascal, Gérard, Elarouci, Nabila, Ayadi, Mira, Adam, René, Azoulay, Daniel, Castaing, Denis, Vibert, Eric, Cherqui, Daniel, Samuel, Didier, Sa Cuhna, Antonio, Marchio, Agnès, Pineau, Pascal, Guettier, Catherine, Reyniès, Aurélien, Faivre, Jamila

“…Background and Aims Intrahepatic cholangiocarcinoma (ICC) is a severe malignant tumor in which the standard therapies are mostly ineffective. The biological…”
Get full text

HBV prophylaxis after liver transplantation: close to the full success but at the price of long-term prophylaxis adapted to the risk of HBV recurrence by Roche, Bruno, Samuel, Didier

Get full text

Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients by Ichai, Philippe, Saliba, Faouzi, Baune, Patricia, Daoud, Asma, Coilly, Audrey, Samuel, Didier

“…Under normal circumstances and mainly in ICUs hosting immunocompromised patients, ICU rooms are equipped with positive air room pressure in order to protect…”
Get full text

Prevention of decompensation in cirrhosis: a new youth for β blockers by Levy, Sharon, Samuel, Didier

“…The natural history of cirrhosis can be described as a continuum from a compensated phase to decompensation and liver failure, marked by the development of…”
Get full text

The impact of treatment of hepatitis C with DAAs on the occurrence of HCC by Roche, Bruno, Coilly, Audrey, Duclos‐Vallee, Jean Charles, Samuel, Didier

“…Hepatitis C virus infection is a major cause of chronic hepatitis resulting in cirrhosis and hepatocellular carcinoma (HCC). The recent introduction of direct…”
Get full text

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors by De Martin, Eleonora, Michot, Jean-Marie, Papouin, Barbara, Champiat, Stéphane, Mateus, Christine, Lambotte, Olivier, Roche, Bruno, Antonini, Teresa Maria, Coilly, Audrey, Laghouati, Salim, Robert, Caroline, Marabelle, Aurélien, Guettier, Catherine, Samuel, Didier

“…[Display omitted] •Acute hepatitis resulting from treatment of metastatic cancer with immune checkpoint inhibitors is rare.•Immune-mediated hepatitis diagnosis…”
Get full text

Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France by Mariani, Louise-Laure, Lozeron, Pierre, Théaudin, Marie, Mincheva, Zoia, Signate, Aissatou, Ducot, Beatrice, Algalarrondo, Vincent, Denier, Christian, Adam, Clovis, Nicolas, Guillaume, Samuel, Didier, Slama, Michel S., Lacroix, Catherine, Misrahi, Micheline, Adams, David

“…Objective To compare the natural history of familial transthyretin amyloid polyneuropathies (FAP) due to the Val30Met, Ser77Tyr, and Ile107Val mutations in…”
Get full text

FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis by Coilly, Audrey, Desterke, Christophe, Guettier, Catherine, Samuel, Didier, Chiappini, Franck

“…Nonalcoholic fatty liver (NAFLD) may progress to nonalcoholic steatohepatitis (NASH) and ultimately to cirrhosis and hepatocellular carcinoma (HCC). Prognostic…”
Get full text

Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of Cirrhosis by De Martin, Eleonora, Rayar, Michael, Golse, Nicolas, Dupeux, Margot, Gelli, Maximiliano, Gnemmi, Viviane, Allard, Marc Antoine, Cherqui, Daniel, Sa Cunha, Antonio, Adam, Rene, Coilly, Audrey, Antonini, Teresa Maria, Guettier, Catherine, Samuel, Didier, Boudjema, Karim, Boleslawski, Emmanuel, Vibert, Eric

“…This multicenter study compares the outcomes of patients with cirrhosis undergoing liver transplantation (LT) or liver resection (LR) between January 2002 and…”
Get full text

Management of Fulminant Hepatitis B by Ichai, Philippe, Samuel, Didier

“…Purpose of Review Acute HBV infection and acute exacerbations of chronic HBV infection can cause acute liver injury (ALI) or fulminant hepatitis (FH). At this…”
Get full text

Early Liver Transplantation for Severe Alcoholic Hepatitis by Mathurin, Philippe, Moreno, Christophe, Samuel, Didier, Dumortier, Jérôme, Salleron, Julia, Durand, François, Castel, Hélène, Duhamel, Alain, Pageaux, Georges-Philippe, Leroy, Vincent, Dharancy, Sébastien, Louvet, Alexandre, Boleslawski, Emmanuel, Lucidi, Valerio, Gustot, Thierry, Francoz, Claire, Letoublon, Christian, Castaing, Denis, Belghiti, Jacques, Donckier, Vincent, Pruvot, François-René, Duclos-Vallée, Jean-Charles

“…Six months of abstinence is typically required before transplantation for alcoholic liver disease. In this study, early liver transplantation improved the…”
Get full text

Etiology and prognosis of fulminant hepatitis in adults by Ichai, Philippe, Samuel, Didier

“…Key Points 1 Establishing the cause of fulminant hepatitis is an important step in the management of acute liver failure, so that specific therapy can be…”
Get full text

Update of the statements on biology and clinical impact of occult hepatitis B virus infection by Raimondo, Giovanni, Locarnini, Stephen, Pollicino, Teresa, Levrero, Massimo, Zoulim, Fabien, Lok, Anna S., Allain, Jean-Pierre, Berg, Thomas, Bertoletti, Antonio, Brunetto, Maurizia Rossana, Bruno, Raffaele, Chen, Ding-Shinn, Coppola, Nicola, Cornberg, Markus, Craxì, Antonio, Dandri, Maura, Di Marco, Vito, Ferrari, Carlo, Gaeta, Giovanni Battista, Glebe, Dieter, Guidotti, Luca G., Kramvis, Anna, Lampertico, Pietro, Li, Chengyao, Liang, Jake, Marzano, Alfredo, Michalak, Thomas I., Pawlotsky, Jean-Michel, Prati, Daniele, Puoti, Massimo, Samuel, Didier, Soriano, Vincent, Squadrito, Giovanni, Sureau, Camille, Trepo, Christian, Yuen, Man-Fung

“…In October 2018 a large number of international experts with complementary expertise came together in Taormina to participate in a workshop on occult hepatitis…”
Get full text

Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry by Belli, Luca Saverio, Perricone, Giovanni, Adam, Rene, Cortesi, Paolo A., Strazzabosco, Mario, Facchetti, Rita, Karam, Vincent, Salizzoni, Mauro, Andujar, Rafael Lopez, Fondevila, Costantino, De Simone, Paolo, Morelli, Cristina, Fabregat-Prous, Joan, Samuel, Didier, Agarwaal, Kosh, Moreno Gonzales, Enrique, Charco, Ramon, Zieniewicz, Krzysztof, De Carlis, Luciano, Duvoux, Christophe

“…[Display omitted] •DAAs have dramatically improved the outcome of cirrhotic patients with HCV infection.•Since the advent of DAAs there has been a 50% decline…”
Get full text

Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors by De Martin, Eleonora, Michot, Jean-Marie, Rosmorduc, Olivier, Guettier, Catherine, Samuel, Didier

“…Immune checkpoint inhibitors (ICIs) improve clinical outcomes in patients suffering from different types of cancer. Liver toxicity is one of the immune-related…”
Get full text

Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant by Halgand, Boris, Desterke, Christophe, Rivière, Lise, Fallot, Guillaume, Sebagh, Mylène, Calderaro, Julien, Bioulac‐Sage, Paulette, Neuveut, Christine, Buendia, Marie‐Annick, Samuel, Didier, Féray, Cyrille

“…Hepatitis B virus (HBV) is a major cause of hepatocellular carcinoma (HCC). However, very little is known about the replication of HBV in HCC tissues. We…”
Get full text

COVID-19 in an international European liver transplant recipient cohort by Becchetti, Chiara, Zambelli, Marco Fabrizio, Pasulo, Luisa, Donato, Maria Francesca, Invernizzi, Federica, Detry, Olivier, Dahlqvist, Géraldine, Ciccarelli, Olga, Morelli, Maria Cristina, Fraga, Montserrat, Svegliati-Baroni, Gianluca, van Vlierberghe, Hans, Coenraad, Minneke J, Romero, Mario Cristobal, de Gottardi, Andrea, Toniutto, Pierluigi, Del Prete, Luca, Abbati, Claudia, Samuel, Didier, Pirenne, Jacques, Nevens, Frederik, Dufour, Jean-François

“…Knowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of…”
Get more information

Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients by Chiappini, Franck, Coilly, Audrey, Kadar, Hanane, Gual, Philippe, Tran, Albert, Desterke, Christophe, Samuel, Didier, Duclos-Vallée, Jean-Charles, Touboul, David, Bertrand-Michel, Justine, Brunelle, Alain, Guettier, Catherine, Le Naour, François

“…Nonalcoholic steatohepatitis (NASH) is a condition which can progress to cirrhosis and hepatocellular carcinoma. Markers for NASH diagnosis are still lacking…”
Get full text

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial by Manns, Michael, Prof, Samuel, Didier, Prof, Gane, Edward J, Prof, Mutimer, David, Prof, McCaughan, Geoff, Prof, Buti, Maria, Prof, Prieto, MartÍn, MD, Calleja, José Luis, MD, Peck-Radosavljevic, Markus, Prof, Müllhaupt, Beat, Prof, Agarwal, Kosh, MD, Angus, Peter, Prof, Yoshida, Eric M, MD, Colombo, Massimo, Prof, Rizzetto, Mario, Prof, Dvory-Sobol, Hadas, PhD, Denning, Jill, MA, Arterburn, Sarah, MS, Pang, Phillip S, MD, Brainard, Diana, MD, McHutchison, John G, MD, Dufour, Jean-François, MD, Van Vlierberghe, Hans, Prof, van Hoek, Bart, Prof, Forns, Xavier, MD

“…Summary Background Treatment options are limited for patients infected by hepatitis C virus (HCV) with advanced liver disease. We assessed the safety and…”
Get full text